Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy
3-11-2020Cross-posted from NIAID NewsroomDolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women.The antiretrov…
NIAID Newsroom
NIH Study Finds Lower Concentration of PrEP Drug in Pregnant Young Women
3-9-2020Cross-posted from NIAID NewsroomAmong African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug tenof…
Superior AIDS-Kaposi’s Sarcoma Treatment Improves Outcomes in Resource-Limited Settings
3-9-2020Cross-posted from NIAID NewsroomThe cancer drug paclitaxel and a suppressive regimen of antiretroviral therapy (ART) is an effective treatment for AIDS-related …
Drug-Delivery Technology Leads to Sustained HIV Antibody Production in NIH Study
3-9-2020Cross-posted from NIAID NewsroomA new approach to direct the body to make a specific antibody against HIV led to sustained production of that antibody for more …
NIH-Funded Clinical Trial to Test PrEP, Dapivirine Ring for Safety in Pregnant Women
2-13-2020Cross-posted from NIAID NewsroomThe first clinical trial specifically designed to test the safety of the monthly dapivirine vaginal ring in pregnant women has …
Experimental HIV Vaccine Regimen Ineffective in Preventing HIV
2-3-2020NIAID has stopped administration of investigational vaccinations in its HVTN 702 clinical trial taking place in South Africa.
NIAID Launches First Clinical Trial to Test Antibody–Drug Combination for Long-Acting HIV Treatment
1-22-2020Cross-posted from NIAID NewsroomThe first clinical trial to test the combination of a long-acting anti-HIV drug plus a powerful HIV antibody as a long-acting tr…
Efforts to End the HIV Epidemic Must Not Ignore People Already Living With HIV
12-16-2019
Opioid Epidemic Is Increasing Rates of Some Infectious Diseases
4-12-2019The U.S. faces a converging public health crisis as the nation’s opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS.
Researchers Report High Rate of Viral Suppression Among People New to HIV Care
3-8-2019The findings from the iENGAGE study underscore the benefits of linking people with HIV to treatment services soon after diagnosis.